THC-Victory

Dutch Passion has built its reputation on pushing cannabis genetics forward. The company's groundbreaking work—most notably the development of feminised seeds—established them as true innovators. This latest achievement represents another milestone: the market's first commercially available THCV-dominant strain. THC-Victory emerged after extensive breeding efforts to create a stable cannabinoid profile featuring equal parts THC and THCV in a 1:1 ratio. THCV (tetrahydrocannabivarin) represents a fascinating and relatively unexplored cannabinoid with significant potential for medical applications. In most cannabis strains, THCV exists only in trace amounts and typically acts as an antagonist to THC, moderating its intensity. The full therapeutic scope of THCV remains under investigation and requires additional clinical study. This strain develops into a medium-height plant characterized by a slower start during early growth phases. Once the plant passes the third internode, growth rate and plant vigor accelerate noticeably. Growers can expect moderate production levels. The aromatic profile emphasizes citrus notes. Laboratory analysis shows the resinous glands deliver approximately 6-8% THC alongside 6-8% THCV, creating the distinctive balanced cannabinoid composition.